ArticleCancers2023

A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells.

Genesio Di Muro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.